Showcase Your Solutions to the Industry’s Most Active Covalent Innovators
As covalent drug discovery and development advances from early research into translational science, IND-enabling studies, and clinical development, drug developers are facing increasing pressure to improve selectivity, predict off-target toxicity, optimise PK/PD strategies, and successfully translate promising candidates into the clinic.
To overcome these challenges, teams are actively investing in new technologies, platforms, and specialist partnerships that can improve target engagement, covalent screening, chemoproteomics, assay development, mass spectrometry, computational modelling, and preclinical development workflows.
The 4th Covalent Drug Discovery & Development Summit provides a unique opportunity to position your organisation in front of the scientists and decision-makers driving the next generation of covalent therapeutics. Whether your solutions support covalent library design, AI-driven drug discovery, protein analysis, toxicology assessment, PK/PD modelling, or IND-enabling services, this is your chance to demonstrate how your technologies can accelerate development, reduce risk, and help bring safer covalent drugs to patients faster.
Networking for the Covalent Drug Discovery Community
- Speed Networking
Connect with experts in covalent drug discovery, medicinal chemistry, chemoproteomics, and translational science to exchange strategies for overcoming selectivity and toxicity challenges.
- Networking Breaks
Continue discussions on covalent inhibitor design, screening technologies, target engagement, and clinical translation with peers advancing next-generation therapeutics.
- Lunch Networking
Meet drug developers, discovery biologists, DMPK specialists, and chemical biologists shaping the future of covalent therapeutics from hit identification through IND readiness.
- Interactive Roundtable Discussions
Join focused conversations on PK/PD strategy, off-target toxicity, chemoproteomics, and translational challenges impacting covalent drug development.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Thomas Conibear
Business Development Manager
Key Interest Areas
Partner with this covalent meeting to empower and support drug developers in their quest to advance novel covalent therapies to the clinic, get in touch if you have expertise in:
- Powering Precision with Advanced Computational & Quantum Modeling Tools
- Unlocking Chemistry with Covalent & Fragment Libraries
- Driving Hits with Cutting-Edge Screening Technologies
- Enabling Discovery with Tailored Assays
- Decoding Biology with Chemoproteomics & Mass Spectrometry
- Optimizing Candidates with DMPK Studies
- De-Risking Pipelines with Toxicity Testing
What to Expect?
Meet New Clients
Expand your client base within the covalent community by networking face-to-face with dedicated attendees actively seeking solutions to overcome their drug development challenges.
Centre Yourself in Biopharma Dealmaking
Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Demonstrate Your Expertise
Present your work, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverable such as exclusive dinners to help elevate your brand.